PH30682A - Nutrional product for persons infected with human immunodeficiency virus - Google Patents

Nutrional product for persons infected with human immunodeficiency virus

Info

Publication number
PH30682A
PH30682A PH46849A PH46849A PH30682A PH 30682 A PH30682 A PH 30682A PH 46849 A PH46849 A PH 46849A PH 46849 A PH46849 A PH 46849A PH 30682 A PH30682 A PH 30682A
Authority
PH
Philippines
Prior art keywords
immunodeficiency virus
human immunodeficiency
infected
nutritional product
product
Prior art date
Application number
PH46849A
Other languages
English (en)
Inventor
Frederick O Cope
Normanella T Dewille
Ernest W Richards
Terrence B Mazer
Bonnie C Abbruzzese
Gregor A Snowden
Michael A Chandler
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/069,269 external-priority patent/US5403826A/en
Priority claimed from US08/069,066 external-priority patent/US5480872A/en
Priority claimed from US08/069,264 external-priority patent/US5330972A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PH30682A publication Critical patent/PH30682A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/011Hydrolysed proteins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PH46849A 1993-05-28 1993-09-09 Nutrional product for persons infected with human immunodeficiency virus PH30682A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/069,269 US5403826A (en) 1993-05-28 1993-05-28 Nutritional product for persons infected with human immunodeficiency virus
US08/069,066 US5480872A (en) 1993-05-28 1993-05-28 Method of providing enternal nutritional support to persons infected with human immunodeficiency virus
US08/069,264 US5330972A (en) 1993-05-28 1993-05-28 Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus

Publications (1)

Publication Number Publication Date
PH30682A true PH30682A (en) 1997-09-16

Family

ID=27371464

Family Applications (1)

Application Number Title Priority Date Filing Date
PH46849A PH30682A (en) 1993-05-28 1993-09-09 Nutrional product for persons infected with human immunodeficiency virus

Country Status (15)

Country Link
EP (1) EP0626177B1 (he)
JP (1) JPH089545B2 (he)
KR (1) KR970005330B1 (he)
AT (1) ATE187076T1 (he)
AU (1) AU651284B1 (he)
CA (1) CA2105790C (he)
DE (1) DE69327159T2 (he)
DK (1) DK0626177T3 (he)
ES (1) ES2142842T3 (he)
GR (1) GR3032748T3 (he)
IL (1) IL106975A (he)
NZ (1) NZ248603A (he)
PH (1) PH30682A (he)
PT (1) PT626177E (he)
TW (1) TW492867B (he)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US5759548A (en) 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
JPH11512439A (ja) * 1995-09-14 1999-10-26 エルエックスアール バイオテクノロジー インコーポレイテッド リン脂質の混合物を含む抗アポトーシス活性を有する組成物
US5681600A (en) * 1995-12-18 1997-10-28 Abbott Laboratories Stabilization of liquid nutritional products and method of making
US5958974A (en) * 1996-07-31 1999-09-28 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents
US5908862A (en) * 1996-07-31 1999-06-01 Abbot Laboratories Water-miscible esters of mono--and diglycerides having antibacterial activity and their use in inhibiting infection
US5981587A (en) * 1996-07-31 1999-11-09 Abbott Laboratories Water-miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
US5866606A (en) * 1996-07-31 1999-02-02 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as anti-microbial agents
EP0918742B1 (en) * 1996-07-31 2002-09-18 Abbott Laboratories Water-miscible esters of monoglycerides having antimicrobial activity
US6495532B1 (en) 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6200950B1 (en) * 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
US6413556B1 (en) 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
EP1236405B1 (en) * 2001-03-01 2006-06-21 Societe Des Produits Nestle S.A. Hypoallergenic formulae inducing oral tolerance to soy proteins
EP1281325A1 (en) * 2001-07-30 2003-02-05 Societe Des Produits Nestle S.A. Nutritional composition preventing bacterial overgrowth
JP4554149B2 (ja) * 2002-11-28 2010-09-29 雅美 森山 レトロウイルス感染症治療薬
RU2006111443A (ru) * 2003-09-10 2006-09-10 Юнилевер Н.В. (Nl) Пищевая композиция
EP1723951A1 (en) 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
MXPA06015071A (es) 2004-06-22 2007-08-06 Nutricia Nv Mejoramiento de la integridad de barrera con acidos grasos en pacientes con vih.
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
JP5098198B2 (ja) * 2005-03-28 2012-12-12 大正製薬株式会社 銅化合物配合組成物
WO2007063141A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Producto alimenticio para la nutrición por vía enteral u oral
WO2007063142A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Mezcla de proteínas y su utilización para preparar un producto destinado a la alimentación oral o enteral
WO2007063143A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Mezcla de lipidos y su utilización para preparar un producto destinado a la adminitracion enteral u oral
WO2007087825A1 (en) * 2006-01-31 2007-08-09 Parsroos Co. Use of a combination of ethanolic rosa sp . , urtica dioica and tanacetum vulgare extracts, further comprising selenium and urea and having been exposed to a pulsed electromagnetic field, for the preparation of a medicament for immunostimulation and/or treatment of hiv infections
JP5181486B2 (ja) * 2006-02-16 2013-04-10 大正製薬株式会社 亜鉛化合物配合経口用組成物
JP2007246509A (ja) * 2006-02-16 2007-09-27 Taisho Pharmaceut Co Ltd 銅化合物配合経口用組成物
JP5619014B2 (ja) * 2008-10-10 2014-11-05 ソレイ リミテッド ライアビリティ カンパニー 高カロリー経腸製剤
EP3247224A4 (en) * 2014-09-01 2018-08-15 Vadakkemuri, Mathew Jolly Optimized nutrient food

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3680346D1 (de) * 1985-01-29 1991-08-29 Abbott Lab Enterales hypoallergenisches ernaehrungsrezept.
SE8601828D0 (sv) * 1986-04-21 1986-04-21 Novo Industri As Enteral diet product and agent for production thereof
WO1988001861A1 (en) * 1986-09-17 1988-03-24 Baxter Travenol Laboratories, Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases
DK3991D0 (da) * 1991-01-10 1991-01-10 Novo Nordisk As Fremgangsmaade til fremstilling af et proteinhydrolysat
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat

Also Published As

Publication number Publication date
ATE187076T1 (de) 1999-12-15
EP0626177A2 (en) 1994-11-30
DE69327159T2 (de) 2000-07-13
EP0626177B1 (en) 1999-12-01
PT626177E (pt) 2000-05-31
NZ248603A (en) 1994-12-22
JPH06340545A (ja) 1994-12-13
TW492867B (en) 2002-07-01
CA2105790A1 (en) 1994-11-29
KR970005330B1 (ko) 1997-04-15
AU651284B1 (en) 1994-07-14
DE69327159D1 (de) 2000-01-05
ES2142842T3 (es) 2000-05-01
EP0626177A3 (en) 1995-02-22
IL106975A0 (en) 1993-12-28
CA2105790C (en) 1998-07-28
GR3032748T3 (en) 2000-06-30
DK0626177T3 (da) 2000-05-08
IL106975A (he) 1996-01-19
JPH089545B2 (ja) 1996-01-31

Similar Documents

Publication Publication Date Title
PH30682A (en) Nutrional product for persons infected with human immunodeficiency virus
CA2372614A1 (en) Process and product for enhancing immune response in companion animal using a combination of antioxidants
MY112705A (en) Tryglycerides
DE69331528D1 (de) Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
BR9712259A (pt) Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.
AU579696B2 (en) Disposable, underpants, such as child's training pants and the like
CA2105791A1 (en) Nutrition for Persons Undergoing Radiation Therapy and/or Chemotherapy
ATE88631T1 (de) Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
FI894673A0 (fi) Produkter innehaollande psyllium.
ES2044796T1 (es) Material alimenticio compuesto para economizar la secrecion de insulina.
IL67978A0 (en) Human immune interferon,its preparation and purification and pharmaceutical compositions containing it
GB8523338D0 (en) Treatment of obesity
CA2133610A1 (en) Additive for Use in Feed for Sows and Feed for Sows
AU8230187A (en) N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
IL93988A0 (en) Substituted 1,8-naphthyridines,their preparation and medicaments comprising them
ATE178615T1 (de) Verwendung eines dekapeptids mit benzodiazepinischer wirkung zur herstellung von arzneimitteln und diätzusätzen
AU601787B2 (en) Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxy-acetic acids, new intermediate products, processes for their preparation and their use as medicaments
IL102065A0 (en) Peptides useful in regulating the immune and nervous systems,their preparation and pharmaceutical compositions containing them
TH8505S (th) ที่ป้อนน้ำผลไม้
AU8246687A (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon
Guembel Change of arachidonic acid and docosa-hexaen acid speculum in the serum of people having heart trouble on a coronary diet with mackerel.).
Wenderoth Aspects of the new eicosanoid-research.).
IT8920225A0 (it) Integratori dietetici, in particolare per condizioni di accresciuto catabolismo proteico.
Klokova et al. Effects of hyperbaric oxygenation on activation of immunocompetent cells and lipid peroxidation under immunization by heterologous erythrocytes
Fukayama Immunological responses in the aged with bacterial infection